Macular microvasculature in patients with thyroid-associated orbitopathy: a cross-sectional study

Macular microvasculature in patients with thyroid-associated orbitopathy: a cross-sectional study

Abstract Purpose The aim of this study was to evaluate macular blood flow in patients with thyroid-associated orbitopathy (TAO) as compared to healthy subjects. The inflammatory nature of the disease, as well as the vascular congestion caused by the increase in the volume of orbital soft tissue and...

Full description

Bibliographic Details
Main Authors:	Mojtaba Abrishami, Aliakbar Sabermoghaddam, Zeinab Salahi, Elham Bakhtiari, Mehrdad Motamed Shariati
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Series:	Thyroid Research
Subjects:	Thyroid-associated orbitopathy Thyroid vasculopathy Optical imaging Macular flow density
Online Access:	https://doi.org/10.1186/s13044-023-00175-3

Similar Items

Macular retinal and choroidal thickness profile in patients with thyroid‐associated orbitopathy compared to healthy individuals: A cross‐sectional study
by: Aliakbar Sabermoghaddam, et al.
Published: (2023-10-01)

Effectiveness of educational materials on levels of knowledge of thyroid associated orbitopathy in an endocrinology clinic
by: Wajiha J. Kheir, et al.
Published: (2023-12-01)

Concurrent occurrence of thyroid-associated orbitopathy and idiopathic orbital inflammatory diseases
by: Sarala Sankar, et al.
Published: (2022-01-01)

Characteristics of Optic Disc and Visual Field Changes in Patients with Thyroid-Associated Orbitopathy and Open-Angle Glaucoma
by: Chih-Kang Hsu, et al.
Published: (2021-08-01)

Dural Carotid-cavernous Fistula Mimicking Thyroid Orbitopathy
by: Aysel Pelit, et al.
Published: (2019-12-01)

Thyroid Orbitopathy and Dry Eye
by: Özge Saraç, et al.
Published: (2011-10-01)

Multihead Neural Network for Multiple Segmented Images-Based Diagnosis of Thyroid-Associated Orbitopathy Activity
by: Sanghyuck Lee, et al.
Published: (2024-01-01)

Glucocorticoid therapy reduces ocular hypertension in active moderate-severe thyroid-associated orbitopathy
by: Chengyang Tang, et al.
Published: (2022-09-01)

A Mimicking Situation Of Active Disease In Thyroid Orbitopathy: The Use Of Topical Prostaglandin Analogs
by: Aydın Yıldız
Published: (2017-05-01)

Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
by: Lilly H. Wagner, et al.
Published: (2022-11-01)

A Tear Metabolomic Profile Showing Increased Ornithine Decarboxylase Activity and Spermine Synthesis in Thyroid-Associated Orbitopathy
by: Benjamin Billiet, et al.
Published: (2022-01-01)

Editorial: News in Graves’ orbitopathy: patients management and treatments
by: Giulia Lanzolla, et al.
Published: (2023-08-01)

Improvement of Ocular Surface Disease by Lateral Tarsoconjunctival Flap in Thyroid-Associated Orbitopathy Patients with Lid Retraction
by: Chih-Kang Hsu, et al.
Published: (2022-05-01)

Clinical Significance of Corneal Striae in Thyroid Associated Orbitopathy
by: Xulin Liao, et al.
Published: (2023-03-01)

Long-term follow-up of surgical treatment of thyroid-associated orbitopathy restrictive strabismus
by: Gustavo Savino, et al.
Published: (2022-11-01)

Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
by: Edelyn Christina, et al.
Published: (2023-06-01)

Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
by: Jakub Supronik, et al.
Published: (2022-11-01)

Survey on selenium clinical supplementation in autoimmune thyroid disease
by: Liliana Ribeiro Santos, et al.
Published: (2023-02-01)

Current imaging methods for assessing Graves` orbitopathy activity with particular emphasis on FDG-PET
by: Anna Ochmann, et al.
Published: (2023-08-01)

Thyroid Eye Disease
by: Ramy Rashad, et al.
Published: (2022-12-01)

How Age Affects Graves’ Orbitopathy—A Tertiary Center Study
by: Michael Oeverhaus, et al.
Published: (2024-01-01)

Selenium supplements: is it advisable to use them in treatment of pathology of the thyroid gland?
by: V. Katerenchuk, et al.
Published: (2022-04-01)

Subcutaneous tocilizumab for active thyroid eye disease refractory to orbital radiation and systemic steroids in tobacco smokers
by: Shanlee M Stevens, et al.
Published: (2022-01-01)

A Comparison of Observational Studies on Subfoveal Choroidal Thickness Measured with OCT according to the Level of Thyroid Eye Disease Activity—Systematic Review and Meta-Analysis
by: Małgorzata Kowalik-Jagodzińska, et al.
Published: (2023-07-01)

Are severe forms of thyroid eye disease common in the indian population? Clinical characteristics of 136 patients from a tertiary eye care centre
by: Dhakshini L Subramaniam, et al.
Published: (2023-01-01)

Thyroid disease‐specific quality of life questionnaires ‐ A systematic review
by: Verena Uslar, et al.
Published: (2022-09-01)

How patients experience thyroid eye disease
by: Terry J. Smith, et al.
Published: (2023-11-01)

Antithymocyte Globulin as Second-Line Therapy in Graves Orbitopathy—Preliminary Results From a Prospective Single-Center Study
by: Monika Sarnat-Kucharczyk, et al.
Published: (2022-05-01)

Functional TSH receptor antibodies in children with autoimmune thyroid diseases
by: Karolina Stożek, et al.
Published: (2018-02-01)

Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
by: Georgios Boutzios, et al.
Published: (2023-06-01)

Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review
by: Nadia Sawicka-Gutaj, et al.
Published: (2022-11-01)

Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy
by: Kenneth K. H. Lai, et al.
Published: (2023-05-01)

Optic nerve head optical coherence tomography angiography findings in patients with thyroid eye disease: a case–control study
by: Aliakbar Sabermoghaddam, et al.
Published: (2022-09-01)

Steroid-resistant Graves' orbitopathy: Therapeutic options
by: Klet Sanja, et al.
Published: (2023-01-01)

Orbital corticosteroid injections for the treatment of active thyroid eye disease
by: Kevin T. Eid, et al.
Published: (2024-01-01)

Teprotumumab: a disease modifying treatment for graves’ orbitopathy
by: Michelle Ting, et al.
Published: (2020-07-01)

Influence of biological sex, age and smoking on Graves’ orbitopathy – a ten-year tertiary referral center analysis
by: Michael Oeverhaus, et al.
Published: (2023-04-01)

Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis
by: Nicole Tsz Yan Wong, et al.
Published: (2023-08-01)

Correlation between choroidal vascularity and retrobulbar ocular blood flow changes and thyroid-associated ophthalmopathy activity: a cross-sectional study
by: Xinghong Sun, et al.
Published: (2024-02-01)

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
by: Tülay Şimşek, et al.
Published: (2017-01-01)